Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

4.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.4K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
Lineage Commitment01:21

Lineage Commitment

4.6K
Commitment is the  process whereby stem cells:
4.6K
Forced Transdifferentiation01:28

Forced Transdifferentiation

2.5K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
2.5K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.9K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.9K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

4.5K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

OT-55 reshapes tolerogenic BH3-mimetic-induced apoptosis toward immunogenic cell death in acute myeloid leukemia, potentiating PD-1/Tim-3 blockade.

Cell death & disease·2026
Same author

Selective HDAC6 inhibition perturbs autophagy and enhances integrated stress response-mediated immunogenic apoptosis in chronic myeloid leukemia.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Minimal Residual Disease in Oncology: From Cure to Longitudinal Patient Management.

Cancers·2026
Same author

Pancreatic Cancer Organoids: Modeling Disease and Guiding Therapy.

Cancers·2025
Same author

TP53-agnostic lethality through combined pan-HDAC and CDK inhibition in acute myeloid leukemia.

Cancer letters·2025
Same author

Martinostat as a novel HDAC inhibitor to overcome tyrosine kinase inhibitor resistance in chronic myeloid leukemia.

Clinical epigenetics·2025

Related Experiment Video

Updated: Apr 14, 2026

Modeling Chemotherapy Resistant Leukemia In Vitro
08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

9.7K

Natural compounds and pharmaceuticals reprogram leukemia cell differentiation pathways.

Franck Morceau1, Sébastien Chateauvieux1, Marion Orsini1

  • 1Laboratoire de Biologie Moléculaire et Cellulaire du Cancer, Hôpital Kirchberg, 9, rue Edward Steichen, L-2540 Luxembourg, Luxembourg.

Biotechnology Advances
|April 19, 2015
PubMed
Summary

Cancer cell differentiation, particularly in leukemia, offers a therapeutic strategy to halt proliferation and induce cell death. Various natural and synthetic compounds show promise in promoting this differentiation process.

Keywords:
CancerDifferentiation therapyDrug developmentGene expressionLeukemiaNatural compounds

More Related Videos

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

10.6K
Directed Differentiation of Induced Pluripotent Stem Cells towards T Lymphocytes
12:47

Directed Differentiation of Induced Pluripotent Stem Cells towards T Lymphocytes

Published on: May 14, 2012

19.5K

Related Experiment Videos

Last Updated: Apr 14, 2026

Modeling Chemotherapy Resistant Leukemia In Vitro
08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

9.7K
Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

10.6K
Directed Differentiation of Induced Pluripotent Stem Cells towards T Lymphocytes
12:47

Directed Differentiation of Induced Pluripotent Stem Cells towards T Lymphocytes

Published on: May 14, 2012

19.5K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Cancer cells, especially leukemia, often exhibit an undifferentiated state, resisting apoptosis and proliferating uncontrollably.
  • Cell differentiation is a complex process involving intricate gene regulatory networks, crucial for normal development and maturation.
  • Inducing cancer cell differentiation is a recognized therapeutic strategy to arrest proliferation and promote cell death.

Purpose of the Study:

  • To explore the potential of inducing cancer cell differentiation as a therapeutic approach.
  • To review molecules effective in promoting cancer cell differentiation, particularly in leukemia.
  • To highlight the role of natural and synthetic compounds in differentiation therapy.

Main Methods:

  • Review of scientific literature on cancer cell differentiation and therapeutic agents.
  • Analysis of studies investigating the effects of various compounds on hematopoietic and osteogenic pathways.
  • Examination of in vitro and in vivo experimental data on differentiation agents.

Main Results:

  • The undifferentiated state is a hallmark of many cancer cells, including leukemia.
  • All-trans retinoic acid (ATRA) is a key agent in differentiation therapy for acute myeloid leukemia.
  • Numerous natural and synthetic compounds (alkaloids, flavonoids, polyphenols) have demonstrated efficacy in inducing differentiation, alone or with ATRA.

Conclusions:

  • Cancer cell differentiation represents a viable therapeutic avenue for cancer treatment, especially leukemia.
  • A diverse range of molecules, including natural products, can effectively induce cancer cell differentiation.
  • Further research into these differentiating agents holds promise for novel cancer therapies.